Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption

Area of Science:

• Biomaterials Science
• Orthopedic Research
• Cell Biology

Background:

• Wear particle-induced bone resorption is a key factor in aseptic implant loosening.
• Polymethylmethacrylate (PMMA) particles trigger macrophage differentiation into bone-resorbing osteoclasts.
• Bisphosphonates, such as etidronate (EHDP), are known inhibitors of osteoclast activity.

Purpose of the Study:

• To investigate the efficacy of incorporating EHDP into bone cement to mitigate PMMA particle-induced bone resorption.
• To evaluate the potential of EHDP-modified bone cement as a therapeutic strategy for preventing osteolysis.

Main Methods:

• PMMA monomer was polymerized with two concentrations of EHDP.
• PMMA particles (1-10 microns) were generated and added to cocultures of mouse monocytes and UMR106 rat osteoblast-like cells.
• Osteoclast differentiation was assessed via tartrate-resistant acid phosphatase (TRAP) staining, and bone resorption was quantified by measuring lacunar pits.

Main Results:

• PMMA particles significantly increased TRAP-positive osteoclast-like cells and lacunar resorption pits compared to controls.
• The addition of PMMA with 20 mg EHDP resulted in significantly fewer resorption pits (p = 0.00006) and TRAP-positive cells.
• EHDP demonstrated a clear inhibitory effect on PMMA particle-induced osteoclastogenesis and bone resorption.

Conclusions:

• Mixing bisphosphonates like EHDP with bone cement effectively inhibits PMMA particle-induced bone resorption.
• This approach offers a promising therapeutic strategy to prevent or manage osteolysis associated with aseptic implant loosening.
• EHDP-modified bone cement could improve the longevity and success of orthopedic implants.